These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1703368)

  • 21. Properties of modified hepatitis B virus surface antigen particles carrying preS epitopes.
    Prange R; Werr M; Birkner M; Hilfrich R; Streeck RE
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2131-40. PubMed ID: 7561750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary cultured normal human hepatocytes for hepatitis B virus receptor studies.
    Mabit H; Vons C; Dubanchet S; Capel F; Franco D; Petit MA
    J Hepatol; 1996 Apr; 24(4):403-12. PubMed ID: 8738726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of albumin binding to hepatitis B virions by monoclonal antibody to the preS2 domain of the viral envelope.
    Quiroga JA; Mora I; Carreño V; Herrera MI; Porres JC; Gerlich WH
    Digestion; 1987; 38(4):212-20. PubMed ID: 2452108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
    Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
    World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applications of human hepatitis B virus preS domain in bio- and nanotechnology.
    Toita R; Kawano T; Kang JH; Murata M
    World J Gastroenterol; 2015 Jun; 21(24):7400-11. PubMed ID: 26139986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A monoclonal antibody specific to the non-epitope region of hepatitis B virus preS1 contributes to more effective HBV detection.
    Zhang Z; Li X; Yi W; Li S; Hu C; Chen A
    Clin Biochem; 2013 Aug; 46(12):1105-1110. PubMed ID: 23608352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B surface antigen variation and protective immunity.
    Howard CR; Allison LM
    Intervirology; 1995; 38(1-2):35-40. PubMed ID: 8666522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic mapping of the surface proteins of infectious hepatitis B virus particles.
    Petit MA; Capel F; Riottot MM; Dauguet C; Pillot J
    J Gen Virol; 1987 Nov; 68 ( Pt 11)():2759-67. PubMed ID: 2445903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection.
    Barnaba V; Franco A; Alberti A; Balsano C; Benvenuto R; Balsano F
    J Immunol; 1989 Oct; 143(8):2650-5. PubMed ID: 2477450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of Novel Hepatitis B Virus PreS/S-Gene Mutations in a Patient with Occult Hepatitis B Virus Infection.
    Chen J; Liu Y; Zhao J; Xu Z; Chen R; Si L; Lu S; Li X; Wang S; Zhang K; Li J; Han J; Xu D
    PLoS One; 2016; 11(5):e0155654. PubMed ID: 27182775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. At least three epitopes are recognized by the human repertoire in the hepatitis B virus group a antigen inducing protection; possible consequences for seroprevention and serodiagnosis.
    Maillard P; Pillot J
    Res Virol; 1998; 149(3):153-61. PubMed ID: 9711539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of preS1-hepatocyte interaction by an array of recombinant human antibodies from naturally recovered individuals.
    Sankhyan A; Sharma C; Dutta D; Sharma T; Chosdol K; Wakita T; Watashi K; Awasthi A; Acharya SK; Khanna N; Tiwari A; Sinha S
    Sci Rep; 2016 Feb; 6():21240. PubMed ID: 26888694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels.
    Pollicino T; Amaddeo G; Restuccia A; Raffa G; Alibrandi A; Cutroneo G; Favaloro A; Maimone S; Squadrito G; Raimondo G
    Hepatology; 2012 Aug; 56(2):434-43. PubMed ID: 22271491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of preS antigens and clinical status during chronic hepatitis B virus infection.
    Taliani G; Rapicetta M; Francisci D; Xiang J; Sarrecchia B; De Bac C; Stagni G
    Med Microbiol Immunol; 1991; 180(5):239-48. PubMed ID: 1762604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen.
    Ryu CJ; Gripon P; Park HR; Park SS; Kim YK; Guguen-Guillouzo C; Yoo OJ; Hong HJ
    J Med Virol; 1997 Jun; 52(2):226-33. PubMed ID: 9179773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B.
    Kohno H; Inoue T; Tsuda F; Okamoto H; Akahane Y
    J Gen Virol; 1996 Aug; 77 ( Pt 8)():1825-31. PubMed ID: 8760433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fine mapping and functional characterization of two immuno-dominant regions from the preS2 sequence of hepatitis B virus.
    Meisel H; Sominskaya I; Pumpens P; Pushko P; Borisova G; Deepen R; Lu X; Spiller GH; Krüger DH; Grens E
    Intervirology; 1994; 37(6):330-9. PubMed ID: 8586531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man.
    Ferrari C; Penna A; Bertoletti A; Cavalli A; Valli A; Schianchi C; Fiaccadori F
    J Clin Invest; 1989 Oct; 84(4):1314-9. PubMed ID: 2529268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-terminal myristylation of HBV preS1 domain enhances receptor recognition.
    De Falco S; Ruvo M; Verdoliva A; Scarallo A; Raimondo D; Raucci A; Fassina G
    J Pept Res; 2001 May; 57(5):390-400. PubMed ID: 11350599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological cross-reactivity between preS2 sequences of the hepatitis B virus envelope proteins corresponding to serological subtypes adw2 and ayw.
    Neurath AR; Kent SB; Adamowicz P; Riottot MM; Price P; Strick N; Parker K; Petit MA; Budkowska A; Girard M
    Mol Immunol; 1987 Jun; 24(6):561-8. PubMed ID: 3657796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.